Skip to content
Friday 14 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,772.67
-0.56%
DAX
26,299.74
0.00%
CAC 40
8,650.56
0.00%
STOXX 50
6,545.47
0.00%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Tuesday 14 April 2026 4:13 pm

Acumetis Launches as a Single Integrated Brand to Transform Life Sciences Commercialization

Acumetis – a new global commercialization company for the life sciences industry – launches today. The company, formed as a combination of five well-known specialist consultancies – Herspiegel, Adivo Associates, Decisive Consulting, Fiecon, and Sixsense Strategy Group – will provide enhanced strategic clarity and critical connection for life sciences businesses with products at all stages of development.

Acumetis is built around a single integrated commercial model and one leadership team, bringing together commercial, insights, medical, market access and patient strategy under one roof. The business offers capability and data to support clients across the product lifecycle, from evaluation and market access strategy through to launch execution and in-market performance.

Acumetis is purposefully built for the demands of modern life sciences commercialization. The name reflects the company’s founding philosophy. ‘Acumen’ – the ability to make good judgments and discern what really matters – and ‘Metis’, the Greek concept of practical wisdom, together define an approach built on rigorous analysis, connected expertise, and measurable results for clients.

Brent Herspiegel, CEO of Acumetis, said: “Acumetis is designed to set a new standard in commercialization. Not just in capability, but in how that capability is delivered. For over two decades, the businesses that form Acumetis have supported more than 200 product launches for some of the most complex and high-stakes assets in life sciences. We’re now bringing our clients our full expertise as one integrated brand, helping them to make the right decision at the moments that matter most. For life sciences companies facing compressed timelines, increasing regulatory complexity and rising pressure to demonstrate value, this is a compelling value proposition.”

As a combined business, Acumetis will employ more than 350 specialists globally, with operational experience spanning more than 50 geographic markets. The company’s client base already includes more than 150 life sciences organizations, among them many of the world’s top global pharmaceutical companies. The founding businesses have collectively supported more than 200 product launches and years of commercialization success.

The company is backed by DFW Capital, a leading middle-market private equity firm investing in companies that provide outsourced business, industrial, or healthcare services in regulated, compliance driven end-markets.

Acumetis is headquartered in Yardley, Pennsylvania, with additional offices across the United States, Canada, South America, United Kingdom, Europe and India. The company’s website launches today at www.acumetisglobal.com.

Further information is available at www.acumetisglobal.com. Media enquiries should be directed to [email protected].

About Acumetis

Acumetis is a global expert commercialization partner purposefully built to help life sciences win in the age of connectivity. With an integrated model spanning the entire asset lifecycle, deep functional and therapeutic-area expertise, and rigorous, outcome-driven thinking, Acumetis reframes complex problems and shapes solutions that are both imaginative and achievable. With more than 350 experts globally and experience across 50+ geographic markets, Acumetis helps clients unlock value, accelerate performance, and deliver better outcomes for patients.

Acumetis. Reframe what’s possible.

About DFW Capital

DFW Capital Partners is a middle-market private equity firm with over $2 billion in assets under management. The firm’s focus for the past 20 years has been investing in founder or management owned companies that provide outsourced business, industrial, or healthcare services in regulated, compliance driven end-markets.

Acumetis brand launch event showcasing pharmaceutical and biotech leaders uniting for life sciences commercialization

View source version on businesswire.com: https://www.businesswire.com/news/home/20260414569348/en/

Contact

[email protected]
+44 7861995400

Abstract

LEADING PHARMACEUTICAL AND BIOTECH CONSULTANCIES COMBINE TO CREATE A FULL-SERVICE COMMERCIALIZATION POWERHOUSE, ACUMETIS

TweetText

Acumetis is formed as a combination of five well-known specialist consultancies – Herspiegel, Adivo Associates, Decisive Consulting, Fiecon, and Sixsense Strategy Group.

Company Logo
Company Logo
Read more

Real Chemistry Launches Real Chemistry ANATOMI, an AI Ecosystem Purpose-Built for Healthcare Commercialization

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Businesswire

Categories

  • Merger/Acquisition

Trending Articles

  • Revolut takes flight with launch of new airport lounges

  • It’s not just Jason Arday, most of sociology is a scam

  • IT consultant ordered to pay £50,000 after being accused of stealing Soho House members’ personal details

  • Grandparents fund university degrees to avoid inheritance tax net

  • Five-star Mayfair hotel hit with HMRC winding-up petition

More from Morning Wire

  • Real Chemistry Launches Real Chemistry ANATOMI, an AI Ecosystem Purpose-Built for Healthcare Commercialization

    Business Wire
  • Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

    Business Wire
  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • Alfasigma to Acquire Nordic Group B.V. Expanding Its Specialty Care Portfolio and Presence in Europe

    Business Wire
  • Quaise Energy Raises $134 Million in Initial Close of Series B to Build World’s First Superhot Geothermal Power Plant

    Business Wire
  • Exclusive: Jobs lost across Labour’s ‘growth potential’ sectors in blow to Burnham

    Politics
    Jonathan Reynolds, Labour MP, in a suit and tie, holding a notebook, looking right, with a building behind him
  • GXP-Storage Expands UK Capacity with Third Restricted-Access Facility at Raunds, Northamptonshire

    Business Wire
  • ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook